Frequency of hidden Hepatitis B and C during screening in patients’ undergone surgical procedures: Single Centered study: Hepatitis B and C During in Patients’ Undergone Surgical Procedures

Arsalan Hussain; Afzal Hussain; M Faheem Afzal; Rutaba Hussain; Maryam Hameed

doi:10.54393/pjhs.v3i07.136

Authors

Arsalan Hussain Innovative Health Concepts Hospital & Research Center, Lahore
Afzal Hussain Innovative Health Concepts Hospital & Research Center, Lahore
M Faheem Afzal PSRD College of Rehabilitation Sciences
Rutaba Hussain Innovative Health Concepts Hospital & Research Center, Lahore
Maryam Hameed Innovative Health Concepts Hospital & Research Center, Lahore

DOI:

https://doi.org/10.54393/pjhs.v3i07.136

Keywords:

Hepatitis B, Hepatitis C, Human immunodeficient Virus

Abstract

Hepatitis is the serious health related concern and spreading rapidly specifically in developing countries, it also led to liver related diseases and hepatocellular carcinoma. While liver disease is an important health problem and having high health cost and leads to poor quality of life and dependency. Objectives: To determine the Incidence of hidden Hepatitis B and C during screening in patients’ undergone surgical procedures reported in a single center. Methods: A cross-sectional study was conducted in Innovative Health Concepts & Research center by using a non-probability convenient sampling technique. The duration of study was 8 months from December 2021 to August 2022 and the study included those subjects who admitted in hospital for some surgical procedure and both genders aged between 25 to 60 years. Those subjects who have multiple neurological or musculoskeletal or endocrinological condition and came for the 2^nd procedure were excluded from the study. Ethical permission was sought from Board of Advance Studies and Expert Review Board of Innovative Health Concepts Hospital (ASRRB/IHC&RC/RH/MED/Letter-003). The assessment for hepatitis B, HCV, and HIV was done through blood test. Data was entered and analyzed through SPSS version 26. Results: The results of study showed mean age of subjects was 43.47±10.17, mean weight was 71.35±10.78. The result showed 04% prevalence of hepatitis B, 4.9% prevalence of hepatitis C and no case reported of Human Immunodeficiency Virus (HIV). Conclusion: The study concluded that there is very low frequency of hepatitis B and C found in subjects undergone surgical procedures

References

Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. Journal of medical virology. 2003 May; 70(1): 74-80. doi: 10.1002/jmv.10361

Marcon PDS, Tovo CV, Kliemann DA, Fisch P, Mattos AA. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study. World Journal of Gastroenterology. 2018 Feb; 24(5): 613-622.

McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clinics in liver disease. 2015 May; 19(2): 223-38. doi: 10.1016/j.cld.2015.01.001

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015 Mar; 65(2): 87-108. doi: 10.3322/caac.21262

Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, et al. Hepatocellular carcinoma: a review. Journal of hepatocellular carcinoma. 2016; 3: 41-53. doi: 10.2147/JHC.S61146

Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016 Apr; 150(4): 835-53. doi: 10.1053/j.gastro.2015.12.041

Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. International journal of molecular sciences. 2019 Mar; 20(6): 1358. doi: 10.3390/ijms20061358

Hemming AW, Berumen J, Mekeel K. Hepatitis B and hepatocellular carcinoma. Clinics in liver disease. 2016 Nov; 20(4): 703-20. doi: 10.1016/j.cld.2016.06.007

Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011 Apr; 140(4): 1182-8. doi: 10.1053/j.gastro.2010.12.032

Mehmood S, Raza H, Abid F, Saeed N, Rehman HM, Javed S, et al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. Journal of Public Health. 2020 Dec; 28(6): 751-64. doi: 10.1007/s10389-019-01081-5

Khan A, Afzal S, Yaqoob A, Fatima R, Haq MU, Junaid K, et al. Epidemiology of viral hepatitis B and C in Punjab, Pakistan: a multicenter cross-sectional study, 2017-18. F1000Research. 2019 Dec; 8(2065): 1-15. doi: 10.12688/f1000research.20174.1

Alamgir H, Cvitkovich Y, Astrakianakis G, Yu S, Yassi A. Needlestick and other potential blood and body fluid exposures among health care workers in British Columbia, Canada. American journal of infection control. 2008 Feb; 36(1): 12-21. doi: 10.1016/j.ajic.2007.03.005

Mehta A, Rodrigues C, Singhal T, Lopes N, D’Souza N, Sathe K, et al. Interventions to reduce needle stick injuries at a tertiary care centre. Indian journal of medical microbiology. 2010 Jan; 28(1): 17-20. doi: 10.4103/0255-0857.58722

World Health Organization. WHO advises on the use of multidisease testing devices for TB, HIV and hepatitis. Geneva. 2017. Availble at: https: //www.who.int/news/item/22-06-2017-who-advises-on-the-use-of-multidisease-testing-devices-for-tb-hiv-and-hepatitis

Laroche MD, Pelissier G, Noël S, Rouveix E. Exposition à risque de transmission virale (AES). La Revue de Médecine Interne. 2019 Apr; 40(4): 238-45. doi: 10.1016/j.revmed.2018.09.002

Assoumou L, Thormann F, Soulié C, Caby F, Dudoit Y, Marcelin AG, et al. Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery. HIV medicine. 2019 May; 20(5): 353-8. doi: 10.1111/hiv.12732

World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization. 2016 Jun: 1-56.

World Health Organization. WHO guidelines on hepatitis B and C testing. World Health Organization. 2017 Feb.

Iqbal S. Prevalence of Hepatitis ‘B’and Hepatitis ‘C’among Preoperative Cataract Patients in the University of Lahore Teaching Hospital. EC Ophthalmology. 2019; 10: 128-34.

Akhtar R, Shams MU, Hanifi AN. Hepatitis B and C, two silent killers: Age and gender based prevalence-A one year study in a tertiary care hospital, Lahore. Pakistan Journal of Medical & Health Sciences. 2017 Dec; 11(4): 1357-1359

Nasim S, Gilani SA, Khan MA. Frequency of Hepatitis B, C and Human Immunodeficiency Virus (HIV) among residents of border area (Wagah Pind) Lahore. Isra Medical Journal. 2019; 11(6): 458-462

Khurram M, Irshad A, Alamgir M, Awan UA, Syed A, Sadia H. Epidemiological Survey of the Prevalence of HCV and HBV among the Factory Workers in the Periphery of Lahore. BioScientific Review. 2021 May; 3(1): 25-33. doi: 10.32350/BSR.0301.03

Ahmed A, Hashmi FK, Khan GM. HIV outbreaks in Pakistan. The Lancet HIV. 2019 Jul; 6(7): e418. doi: 10.1016/S2352-3018(19)30179-1